Search filters

List of works by Pol Specenier

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma

scientific article published on 21 February 2016

A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck

scientific article published on 6 August 2009

A phase I study of volasertib combined with afatinib, in advanced solid tumors

scientific article

A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy

scientific article published on 28 June 2010

Advances in the systemic treatment of head and neck cancers.

scientific article published on May 2010

Afatinib in squamous cell carcinoma of the head and neck

scientific article published on 10 May 2016

Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance

scientific article published on 02 July 2013

Authors' response letter: Quality of life in oropharyngeal cancer: a structured review of the literature

scientific article published on 14 February 2019

Bevacizumab in glioblastoma multiforme.

scientific article published on January 2012

CONCERT-1, an additional piece in the puzzle of (bio)-(chemo)-radiation

scientific article published on November 2016

Cetuximab in the treatment of squamous cell carcinoma of the head and neck

scientific article published on April 1, 2011

Current concepts for the management of head and neck cancer: chemotherapy.

scientific article published on 19 August 2008

Docetaxel, ifosfamide and cisplatin in solid tumour treatment: a phase I study

scientific article

EORTC 24051: Unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinoma

scientific article published in November 2012

Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.

scientific article published on 28 December 2015

Helical tomotherapy in head and neck cancer: a European single-center experience

scientific article

Incorporating anti-VEGF pathway therapy as a continuum of care in metastatic colorectal cancer

scientific article published on April 2015

Ipilimumab in melanoma

scientific article

Ipilimumab in melanoma

scientific article published in December 2012

Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab

scientific article published on 5 June 2015

Minerva's comment was not evidence based

scientific article published in July 1996

Optimal treatment for recurrent/metastatic head and neck cancer.

scientific article published on October 2010

Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP proteins

scientific article published on 2 September 2014

Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients

scientific article

Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck

scientific article

Quality of life in oropharyngeal cancer: a structured review of the literature

scientific article published on 03 May 2018

Recurrent head and neck cancer: current treatment and future prospects.

scientific article published on March 2008

Study protocol for a randomized controlled trial: tongue strengthening exercises in head and neck cancer patients, does exercise load matter?

scientific article

The role of taxanes and targeted therapies in locally advanced head and neck cancer.

scientific article published on May 2007

Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

scientific article